Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A genome-wide association study in progressive multiple sclerosis.
Martinelli-Boneschi F, Esposito F, Brambilla P, Lindström E, Lavorgna G, Stankovich J, Rodegher M, Capra R, Ghezzi A, Coniglio G, Colombo B, Sorosina M, Martinelli V, Booth D, Oturai AB, Stewart G, Harbo HF, Kilpatrick TJ, Hillert J, Rubio JP, Abderrahim H, Wojcik J, Comi G. Martinelli-Boneschi F, et al. Among authors: wojcik j. Mult Scler. 2012 Oct;18(10):1384-94. doi: 10.1177/1352458512439118. Epub 2012 Mar 28. Mult Scler. 2012. PMID: 22457343
MGAT5 and disease severity in progressive multiple sclerosis.
Esposito F, Wojcik J, Rodegher M, Radaelli M, Moiola L, Ghezzi A, Capra R, Brambilla P, Sorosina M, Giacalone G, Martinelli V, Comi G, Abderrahim H, Martinelli Boneschi F. Esposito F, et al. Among authors: wojcik j. J Neuroimmunol. 2011 Jan;230(1-2):143-7. doi: 10.1016/j.jneuroim.2010.10.026. Epub 2010 Nov 27. J Neuroimmunol. 2011. PMID: 21115203
MGAT5 alters the severity of multiple sclerosis.
Brynedal B, Wojcik J, Esposito F, Debailleul V, Yaouanq J, Martinelli-Boneschi F, Edan G, Comi G, Hillert J, Abderrahim H. Brynedal B, et al. Among authors: wojcik j. J Neuroimmunol. 2010 Mar 30;220(1-2):120-4. doi: 10.1016/j.jneuroim.2010.01.003. Epub 2010 Feb 1. J Neuroimmunol. 2010. PMID: 20117844
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.
Vermersch P, Brieva-Ruiz L, Fox RJ, Paul F, Ramio-Torrenta L, Schwab M, Moussy A, Mansfield C, Hermine O, Maciejowski M; AB07002 Study Group. Vermersch P, et al. Neurol Neuroimmunol Neuroinflamm. 2022 Feb 21;9(3):e1148. doi: 10.1212/NXI.0000000000001148. Print 2022 May. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35190477 Free PMC article. Clinical Trial.
Ergoloid mesylates and ECT.
Sachs GS, Gelenberg AJ, Bellinghausen B, Wojcik J, Falk WE, Farhadi AM, Jenike M. Sachs GS, et al. Among authors: wojcik j. J Clin Psychiatry. 1989 Mar;50(3):87-90. J Clin Psychiatry. 1989. PMID: 2647711 Clinical Trial.
514 results